Politics Eli Lilly reaches deal to bring AI-developed drugs to global market Finance News Mar 29, 2026 A drone view shows the Eli Lilly logo on the company’s office in San Diego, California, Nov. 21, 2025.Mike Blake |… Read More...
Politics Novartis shells out $2 billion for immunology biotech Excellergy Finance News Mar 27, 2026 A sign of Swiss pharmaceutical giant Novartis is seen on the top of a building at Novartis Campus in Basel, northern… Read More...
Politics Merck to buy Terns Pharmaceuticals for $6.7 billion to boost cancer Finance News Mar 25, 2026 Pharma giant Merck is buying U.S. biotech firm Terns Pharmaceuticals for $6.7 billion, the company said… Read More...
Politics Menstrual products prices skyrocketing from inflation, tariffs Finance News Mar 22, 2026 Always products are displayed on a shelf in a supermarket in Sarajevo, Bosnia and Herzegovina October 29, 2024. Dado… Read More...
Politics Eli Lilly’s obesity drug retatrutide clears late-stage diabetes trial Finance News Mar 19, 2026 The Eli Lilly logo appears on the company’s office in San Diego, California, U.S., Nov. 21, 2025.Mike Blake |… Read More...
Politics Icotyde psoriasis pill from J&J to rival Tremfya Skyrizi IL-23 shots Finance News Mar 18, 2026 Signage outside Johnson & Johnson offices in Irvine, California, US, on Friday, Oct. 10, 2025.Kyle Grillot |… Read More...
Politics Zealand stock falls 35% after trial setback, CEO remains optimistic Finance News Mar 6, 2026 Wegovy is produced by pharmaceutical company Novo Nordisk and has been approved for specifically for chronic weight… Read More...
Politics Why Novo Nordisk’s Ireland expansion is key to fighting off Eli Lilly Finance News Mar 2, 2026 Novo Nordisk is investing 432 million euros ($506 million) in a facility in Ireland as it expands its production… Read More...
Retail Jim Cramer’s update on our AI stocks and the rest of the portfolio Finance News Mar 2, 2026 On Friday, the CNBC Investing Club held its February Monthly Meeting, where Jim Cramer and Director of Portfolio… Read More...
Politics These 4 charts show the scale of Novo Nordisk’s woes Finance News Feb 25, 2026 Novo Nordisk was the first company to make a GLP-1 drug for weight loss and became Europe's most valuable company.But… Read More...